Omega Fund Management as of Dec. 31, 2019
Portfolio Holdings for Omega Fund Management
Omega Fund Management holds 14 positions in its portfolio as reported in the December 2019 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Gossamer Bio (GOSS) | 30.4 | $96M | 6.1M | 15.63 | |
| Replimune Group (REPL) | 24.2 | $76M | 5.3M | 14.30 | |
| Morphic Hldg (MORF) | 16.2 | $51M | 3.0M | 17.16 | |
| Translate Bio | 6.3 | $20M | 2.4M | 8.14 | |
| Immunic (IMUX) | 4.2 | $13M | 1.4M | 9.70 | |
| Prevail Therapeutics Ord | 3.4 | $11M | 669k | 15.83 | |
| Paratek Pharmaceuticals | 3.3 | $11M | 2.6M | 4.03 | |
| Essa Pharma (EPIX) | 3.0 | $9.4M | 1.7M | 5.50 | |
| Cidara Therapeutics Inc Common Stock Usd 0.0001 | 2.0 | $6.3M | 1.6M | 3.84 | |
| Fibrogen (FGEN) | 1.8 | $5.6M | 131k | 42.89 | |
| Trevi Therapeutics (TRVI) | 1.5 | $4.7M | 1.3M | 3.75 | |
| Jounce Therapeutics | 1.5 | $4.6M | 530k | 8.73 | |
| Obseva Sa | 1.2 | $3.8M | 999k | 3.82 | |
| Pieris Pharmaceuticals | 0.9 | $2.7M | 751k | 3.62 |
